Startup profile · funding coverage
Kin Health funding, valuation and investors
Free patient-facing AI app that records visits and turns doctor conversations into actionable summaries.
Keep track of Kin Health
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Seed
$9M · May 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$9M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
seed · Los Angeles, CA
Overview
Kin Health offers a free mobile app that records medical appointments and produces plain-language summaries patients can act on and share with caregivers. Founded by physicians Arpan and Amit Parikh with Kyle Alwyn (HeyDoctor, acquired by GoodRx) and GoodRx co-founders Doug Hirsch and Trevor Bezdek as investors/chairmen, Kin raised $9M seed in May 2026 led by Maveron with Eniac Ventures, Pear VC, Town Hall Ventures, and others participating.
Why Kin Health is interesting
Clinician scribes are crowded — Kin targets the patient side of the conversation and monetizes downstream care navigation like GoodRx did.
Product & use cases
Consumer health app: ambient recording of visits, plain-language summaries, personal health record built from conversations, planned care navigation referrals.
- Patients remembering specialist instructions after visits
- Caregivers sharing visit summaries with family
- Downstream lab, pharmacy, and specialist routing (planned revenue)
Key facts
- Seed (May 2026): $9M led by Maveron
- GoodRx founders Hirsch and Bezdek involved
- Free consumer app; downstream monetization model
- 30+ physician angels in round
Funding history (newest first)
Seed
2026-05 $9M- Maveron (lead)
- Eniac Ventures (participant)
- Pear VC (participant)
Source: https://techcrunch.com/2026/05/18/kin-health-raises-9m-to-build-an-ai-notetaker-for-patients/
Investors in our directory
Funds linked from Kin Health's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Permanently free consumer app with GoodRx-style downstream monetization versus subscription patient tools.
Patient ambient AI must avoid hallucinations in medical contexts — Kin emphasizes clinical rigor engine. Free UX drives adoption; revenue depends on ethical downstream routing economics.
-
Heidi / Freed (clinician scribes) adjacent
Provider-side notetakers; Kin is patient-facing.
-
Patient portal visit summaries incumbent
EHR portals with clinician notes, often jargon-heavy.
-
General health record apps adjacent
Apple Health records without conversation capture.
Notable stories
- TechCrunch noted Kin flips the scribe market — $600M+ clinician notetaker revenue vs underserved patients.
- Alwyn sold HeyDoctor to GoodRx in 2019 before founding Kin's technical stack.
Industries
Related funding articles
Venture Capital Tracker pieces that cover Kin Health's financing or category context.
FAQs about Kin Health
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.